Table 1. A summary of the each individual microarray datasets from different GEO dataset.

Study Set	GEO Accession	The platform of dataset	Platform	Samples Containing Mir-145	References	Cancer Type
1	GSE47657	GPL13607	Agilent-028004 SurePrint G3 Human GE 8x60K Microarray	GSM1154161(PC3), GSM1154163(DU145), GSM1154165 (LNCap)	[38]	Prostate cancer
2	GSE24782	GPL10332	Agilent-026652 Whole Human Genome Microarray 4x44K v2	GSM610397(PC3), GSM610398(DU145)	[39]	Prostate cancer
3	GSE58295	GPL4133	Agilent-014850 Whole Human Genome Microarray 4x44K G4112F	GSM1406126 (PC3-8h), GSM1406127 (PC3-16h), GSM1406128 (PC3-24h)	[40]	Prostate cancer
4	GSE37119	GPL10332	Agilent-026652 Whole Human Genome Microarray 4x44K v2	GSM911053 (HNSCC, IMC-3)	[41]	Head and neck squamous cell carcinoma
5	GSE18625	GPL570	[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array	GSM462902, GSM462903, GSM462904, GSM462905	[42]	Colon cancer (Exclude)
6	GSE19737	GPL570	[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array	GSM492843, GSM492844, GSM492845	[43]	Breast cancer
7	GSE20028	GPL4133	Agilent-014850 Whole Human Genome Microarray 4x44K G4112F	GSM500946 (TE2), GSM500948 (TE13)	[44]	Esophageal squamous cell carcinoma
8	GSE19717	GPL4133	Agilent-014850 Whole Human Genome Microarray 4x44K G4112F	GSM492573 (KK47), GSM492575 (T24)	[44]	Bladder cancer